ICH M9 - reverse engineering? [Regulatives / Guidelines]

posted by dshah  – India/United Kingdom, 2020-09-30 09:27 (1327 d 07:58 ago) – Posting: # 21951
Views: 1,137

Dear Marta!

Pls find the recent presentation by FDA on - From General Q1/Q2 Inquiries to Supporting Complex Excipient Sameness. It can be downloaded from - https://sbiaevents.com/files2/Innov-2020-Day-1.zip and see- D1S14-Kozak. It will be useful for BCS based biowaiver approach as well.

Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
23,029 posts in 4,834 threads, 1,644 registered users;
25 visitors (0 registered, 25 guests [including 6 identified bots]).
Forum time: 17:26 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5